About
ProBioGen AG is a CDMO and technology provider for biopharmaceuticals, serving biotech and pharma clients. It develops cell lines, cell banks, processes, analytics, and GMP-manufactured products for proteins, antibodies, viral vectors, and vaccines from Berlin, Germany.
Services
Cell line development
Develops producer cell lines for proteins, antibodies, biosimilars, and viral vector applications.
Cell line development
Cell banking
Generates GMP-compliant master cell banks and working cell banks.
Cell line development
Process development (USP/DSP)
Develops upstream and downstream processes for biologics and advanced therapies.
GMP manufacturing for proteins & antibodies
Produces antibodies and recombinant proteins for clinical use at GMP level.
CDMO: development & manufacturing
Technology transfer
Transfers projects to or from another CDMO with document transfer, support, and troubleshooting.
Analytics & bioassays
Provides analytical services and bioassays to support development and manufacturing.
GMP manufacturing for viral vectors & vaccines
Manufactures viral vectors and vaccines for preclinical and GMP stages.
CDMO: development & manufacturing
Quality & analytical services
Provides quality systems, regulatory support, release testing, and stability studies.
7 more services
- AAV production
- Lentivirus production
- Poxvirus production
- Developability assessment
- Formulation development
- Release testing & stability studies
- Regulatory support
Capabilities
- Assays and studies
- Process development
- Antibodies
- CHO
- AAV
- Lentivirus
- Stability studies
6 more
- Bioreactors
- Bioassays
- Release testing
- Quality analytics
- Analytical services
- Developability assessment
- Scale and capacity
- Up to 300 vials in GMP-certified clean rooms
- 4,600 m² GMP manufacturing facility for ATMPs
- Therapeutic areas
- Biopharmaceuticals
- Gene therapy
- Cell therapy
- Viral vaccines
Instruments and platforms
- Bioreactor systems
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- Viral vector
- Recombinant protein
- Vaccine
- Biosimilar
- Species and models
- CHO
- AGE1.CR.pIX
- AGE1.CR.ReX
- MVA-CR19
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: cell line engineering, manufacturing, and cell banking
Details
- Type
- CRDMO
- Address
- Herbert-Bayer-Straße 8 13086 Berlin, Germany
- Serves
- US, EU, worldwide
- General enquiry
- info@probiogen.de on their site